Other

PepsiCo·Balance Sheet Statement·84 metrics

Breakdown

Metric	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Cumulative Cost Basis	$55B	$55.5B	$56B	$56.9B	$58.5B	$59.3B	$60.9B	$61.5B
Debt Instrument, Fair Value Disclosure	$41B	$42B	$40B	$45B	$47B	$48B	$46B	$49B
Long-Term Debt and Lease Obligation	$36.6B	$38.5B	$37.2B	$39.4B	$39.3B	$44.1B	$42.3B	$42.6B
Trademarks	$13.7B	$13.7B	$13.7B	$14.2B	$14.2B	$13.6B	$13.8B	$13.9B
Commercial paper borrowings outstanding	$4.4B	$2B	—	$4.8B	$7.7B	$3B	—	$5B
Deferred income taxes	$3.9B	$3.7B	$3.5B	$3.5B	$3.1B	$3.5B	$3.8B	$4B
Common stock, shares authorized (in shares)	3.6B	3.6B	3.6B	3.6B	3.6B	3.6B	3.6B	3.6B
Gross Carrying Amount	$2.9B	$2.9B	$2.9B	$2.9B	$3.2B	$3.1B	$3.1B	$3.1B
Equity method investments (Note 11)	$2.7B	$2.6B	$2B	$2B	$2.1B	$2.1B	$2B	$2.1B
Carrying Amount, Hedged Fixed-Rate Debt	—	—	$1.9B	$2B	$2B	$2B	$2B	$2B
Finite-Lived Intangible Assets, Accumulated Amortization	$1.8B	$1.8B	$1.8B	$1.8B	$1.8B	$1.9B	$1.9B	$1.9B
Common stock, shares issued (in shares)	1.4B	1.4B	1.4B	1.4B	1.4B	1.4B	1.4B	1.4B
Gross Unrealized Gains	$800M	$347M	$334M	$430M	$526M	$1.1B	$860M	$745M
Accumulated Other Comprehensive Income Loss Other	$603M	$252M	$237M	$303M	$367M	$777M	$606M	$508M
Treasury stock, shares (in shares)	493M	494M	495M	494M	496M	498M	500M	499M
Gross Assets/Liabilities	$190M	$201M	$246M	$194M	$225M	$185M	$214M	$237M
Derivative Liability	$190M	$201M	$246M	$194M	$225M	$185M	$214M	$237M
Allowance for doubtful accounts	$180M	$166M	$356M	$362M	$231M	$245M	$230M	$225M
AOCI - Cash Flow Hedge Reclassification (Next 12 Months)	$14M	-$10M	$82M	$104M	$86M	$109M	$126M	$181M
Business Combination, Contingent Consideration, Liability	—	—	$0	—	$226M	$180M	$278M	$162M
Noncontrolling interests in subsidiaries	$134M	$152M	$130M	$140M	$141M	$155M	$141M	$153M
Derivative, Net Liability Position, Aggregate Fair Value	$141M	$171M	$208M	$143M	$110M	$88M	$96M	$97M
Common stock, par value (in dollars per share)	$0.02	$0.02	$0.02	$0.02	$0.02	$0.02	$0.02	$0.02
Derivative Collateral Threshold	$0	$0	$0	$0	$0	$0	—	$0
Accrued marketplace spending	—	—	$3.5B	—	—	—	$3.5B	—
amortization corridor	—	—	$0.1	—	—	—	$0.1	—
Cash Collateral for Borrowed Securities	—	—	$447M	—	—	—	$430M	—
Collateral already posted, aggregate fair value	$0	$0	$0	$0	$0	—	$0	$0
Common stock, capital shares reserved for future issuance	—	—	95M	—	—	—	89M	—
Credit-Risk-Related Contingent Features Triggered	$0	$0	$0	$0	$0	$0	$0	$0
Short-term debt and current portion of long-term debt	—	—	$7.1B	—	—	—	$6.9B	—
Less: net unamortized discount	—	—	$267M	—	—	—	$224M	—
Deductible State Tax And Interest Benefits	—	—	$202M	—	—	—	$181M	—
Deferred Tax Liabilities, Gross	—	—	$4.1B	—	—	—	$4.7B	—
Deferred marketplace spending	—	—	$100M	—	—	—	$205M	—
Deferred Tax Asset - capitalized research and development	—	—	$256M	—	—	—	$134M	—
Deferred Tax Assets, Goodwill and Intangible Assets	—	—	$1.6B	—	—	—	$2B	—
Deferred Tax Assets, Gross	—	—	$11.2B	—	—	—	$11.5B	—
Deferred Tax Assets, Net	—	—	$878M	—	—	—	$739M	—
Deferred Tax Assets, Net of Valuation Allowance	—	—	$5B	—	—	—	$5.4B	—
Deferred Tax Assets, Operating Loss Carryforwards	—	—	$6.7B	—	—	—	$6.8B	—
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits	—	—	$104M	—	—	—	$96M	—
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost	—	—	$148M	—	—	—	$141M	—
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other	—	—	$415M	—	—	—	$372M	—
Deferred Tax Assets, Valuation Allowance	—	—	$6.2B	—	—	—	$6.1B	—
Debt guarantee of wholly-owned subsidiary	—	—	$578M	—	—	—	$578M	—
Deferred Tax Liabilities, Other	—	—	$301M	—	—	—	$486M	—
Deferred Tax Liabilities, Property, Plant and Equipment	—	—	$1.9B	—	—	—	$2B	—
Deferred tax liability, recapture of NOL	—	—	$488M	—	—	—	$488M	—
Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year	—	—	5.0%	—	—	—	5.0%	—
Defined Benefit Plan, Ultimate Health Care Cost Trend Rate	—	—	4.0%	—	—	—	4.0%	—
Unrecognized compensation cost related to non-vested awards	—	—	$398M	—	—	—	$329M	—
2028	—	—	$64M	—	—	—	$74M	—
2030	—	—	$59M	—	—	—	$72M	—
2031	—	—	$58M	—	—	—	$63M	—
2027	—	—	$73M	—	—	—	$78M	—
2029	—	—	$60M	—	—	—	$73M	—
Raw materials	—	—	$2.4B	—	—	—	$2.6B	—
Lessee Operating Lease Liability Payments Due	—	—	$4B	—	—	—	$4.5B	—
Lessee Operating Lease Liability Undiscounted Excess Amount	—	—	$568M	—	—	—	$681M	—
Line of Credit Facility, Outstanding Borrowings	$0	$0	$0	—	$0	$0	$0	—
Noncurrent notes and accounts receivable	—	—	$111M	—	—	—	$136M	—
Number of countries in which Visa operates (more than)	—	—	20000.0%	—	—	—	20000.0%	—
Operating Lease Weighted Average Discount Rate Percent	—	—	4.0%	—	—	—	5.0%	—
Operating Loss Carryforwards	—	—	$34B	—	—	—	$35.5B	—
Other Assets, Miscellaneous	—	—	$821M	—	—	—	$923M	—
Other receivables	—	—	$2.2B	—	—	—	$2.5B	—
Phantom Units Granted Under Director Deferral Program, Shares Outstanding	—	—	311K	—	—	—	341K	—
Reporting Unit, Zero or Negative Carrying Amount, Number	—	—	$0	—	—	—	$0	—
Reserves For Income Taxes	—	—	$2.3B	—	—	—	$2.4B	—
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	—	—	$166.64	—	—	—	$162.45	—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	—	—	11.1M	—	—	—	11.3M	—
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	—	—	5.4M	—	—	—	4.8M	—
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value	—	—	$0	—	—	—	$2.5M	—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	—	—	$143.88	—	—	—	$146.60	—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	—	—	$177.8M	—	—	—	$101M	—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	—	—	$119.78	—	—	—	$134.10	—
Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable	—	—	5.4M	—	—	—	6.3M	—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	—	—	$177.8M	—	—	—	$98.4M	—
Significant unobservable input used in level 3 fair value measurement - Other AFS, discount rate assumption	—	—	8.3%	—	—	—	—	—
Trade receivables	—	—	$8.5B	—	—	—	$9.3B	—
Undistributed Earnings of Foreign Subsidiaries	—	—	$11B	—	—	—	$12B	—
Unrecognized tax benefits	—	—	$2.3B	—	—	—	$2.4B	—
Interest accrued	—	—	$469M	—	—	—	$450M	—